Valuation: Inogen, Inc.

Market Cap 140M 123M 117M 105M 199M 13.41B 201M 1.4B 537M 6.86B 525M 514M 21.98B P/E 2026 *
-6.89x
P/E 2027 * -11.1x
Enterprise Value 140M 123M 117M 105M 199M 13.41B 201M 1.4B 537M 6.86B 525M 514M 21.98B EV / Sales 2026 *
0.39x
EV / Sales 2027 * 0.38x
Free-Float
87.05%
Yield 2026 *
-
Yield 2027 * -
1 day-1.86%
1 week+3.54%
1 month-1.86%
3 months-18.29%
6 months-14.72%
Current year-21.58%
1 week 5.2
Extreme 5.2
5.5
1 month 5.04
Extreme 5.045
5.54
Current year 5.04
Extreme 5.045
7.67
1 year 5.04
Extreme 5.045
9.13
3 years 4.13
Extreme 4.13
13.33
5 years 4.13
Extreme 4.13
44.3
10 years 4.13
Extreme 4.13
287.79
Manager TitleAgeSince
Chief Executive Officer 55 2023-11-09
Director of Finance/CFO 48 2026-04-05
Chief Operating Officer 56 2026-07-05
Director TitleAgeSince
Director/Board Member 66 2014-08-05
Chairman 65 2021-12-28
Director/Board Member 59 2022-03-21
Date Insider Type Main position Quantity % Market Cap. Importance
9/1/26 Free

Controller/Auditor

1,500 0.0057%
9/1/26 Free

General Counsel

46,443 0.1750%
9/1/26 Free

Chief Executive Officer

1,500 0.0057%
Change 5-day change 1-year change 3-year change Capi.($)
-1.86%+3.54%-35.50%+0.96% 140M
-2.10%-4.50%-26.21%+2.04% 171B
-0.92%-3.37%-9.40%+10.12% 110B
-0.90%+0.73%-25.50%+0.78% 106B
+0.69%-2.90%-47.25%-11.84% 75.99B
-2.39%-3.85%-3.93%+66.83% 57.3B
-1.63%-1.93%-4.37%-30.76% 48.76B
+3.44%+5.40%+18.51%+60.88% 50.19B
-2.11%+0.03%-18.27%+19.42% 41.14B
-0.40%-1.64%+28.24%-7.51% 32.56B
Average -0.39%-0.96%-12.37%+11.09% 69.31B
Weighted average by Cap. +0.13%-2.07%-16.09%+9.51%

Financials

2026 *2027 *
Net sales 356M 314M 297M 268M 506M 34.17B 513M 3.56B 1.37B 17.47B 1.34B 1.31B 56.01B 373M 328M 311M 281M 529M 35.73B 536M 3.72B 1.43B 18.26B 1.4B 1.37B 58.55B
Net income -20.8M -18.32M -17.35M -15.67M -29.53M -1.99B -29.91M -208M -79.9M -1.02B -78.1M -76.4M -3.27B -13.35M -11.76M -11.14M -10.06M -18.95M -1.28B -19.2M -133M -51.28M -654M -50.13M -49.04M -2.1B
Net Debt - -
Logo Inogen, Inc.
Inogen, Inc. is a global medical technology company offering respiratory products for use in the homecare setting. The Company partners with patients, prescribers, home medical equipment providers, and distributors to make its respiratory therapy products available. It develops, manufactures, and markets respiratory health products, including portable oxygen concentrators (POCs), used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions and the Simeox product for airway clearance treatment. It also distributes the Inogen Voxi 5 stationary oxygen concentrator as well as the Aurora continuous positive airway pressure (CPAP) masks in the United States. Its proprietary Inogen One and Inogen Rove POC systems concentrate the air around the patient to offer a source of supplemental oxygen 24 hours a day, seven days a week with a battery and can be plugged into an outlet when at home, in a car, or in a public place with outlets available.
Employees
753
Date Price Change Volume
26-09-30 US$5.270 -1.86% 267,486
26-09-29 US$5.370 -1.29% 231,991
26-09-28 US$5.440 +1.49% 301,882
26-09-25 US$5.360 +2.49% 615,379
26-09-24 US$5.230 +2.75% 433,638
Trader
-
Investor
-
Global
-
Quality
-
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
5.270USD
Average target price
12.00USD
Spread / Average Target
+127.70%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. INGN Stock